{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:23:36Z","timestamp":1789557816507,"version":"build-2803163510"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The current review broadly summarises the evidence base for pharmacotherapies and adjunctive and alternative therapies in the treatment of eating disorders and disordered eating.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This\u00a0paper\u00a0forms part of a\u00a0Rapid Review\u00a0series examining\u00a0the evidence base in the field of eating disorders. This was\u00a0conducted\u00a0to inform the Australian National Eating Disorder Research and Translation Strategy 2021\u20132030.\u00a0ScienceDirect, PubMed and Ovid\/Medline were searched for included studies published between 2009 and 2021 in English. High-level evidence such as meta-analyses, large population studies and randomised control trials  were\u00a0prioritised, and grey literature excluded. Data from included studies relating to pharmacotherapy, and to adjunctive and alternative therapies in eating disorders, were synthesised and disseminated in the current review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 121 studies were identified, relating to pharmacotherapy (n\u2009=\u200990), adjunctive therapies (n\u2009=\u200921) and alternative therapies (n\u2009=\u200922). Some of the identified studies involved combinations of the above (e.g. adjunctive pharmacotherapy). Evidence of efficacy of interventions across all three categories was very limited with few relevant high quality clinical trials. There was a particular scarcity of evidence around effective treatments for anorexia nervosa (AN). With treatment of bulimia nervosa (BN), fluoxetine has exhibited some efficacy leading to regulatory approval in some countries. With binge eating disorder (BED), recent evidence supports the use of lisdexamfetamine. Neurostimulation interventions show some emerging efficacy in the treatment of AN, BN and BED but some, such as deep brain stimulation can be highly invasive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite widespread use of medications, this Rapid Review has identified a lack of effective medications and adjunctive and alternative therapies in the treatment of EDs. An intensification of high-quality clinical trial activity and drug discovery innovation are required to better assist patients suffering from EDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40337-023-00833-9","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T09:02:19Z","timestamp":1688634139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review"],"prefix":"10.1186","volume":"11","author":[{"given":"Sarah-Catherine","family":"Rodan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvi","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Eating Disorder Research Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Aouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Boakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronny","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Caterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Chelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"Chiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexi","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Dammery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Dzajkovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Fardouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Feneley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber-Marie","family":"Firriolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Foroughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Fuller-Tyszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Fursland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gonzalez-Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethanie","family":"Gouldthorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlea","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hannigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipa","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hickie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kay-Lambkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyza","family":"Koreshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Linardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sloane","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peta","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thy","family":"Meddick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Miskovic-Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mitchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"O\u2019Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Hwa Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Phillipou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Piccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Pinkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn","family":"Raykos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Catherine","family":"Rodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Salter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvashnee","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Spielman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Squire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjani","family":"Utpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenny","family":"Vartanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Wertheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Wilksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"issue":"1","key":"833_CR1","first-page":"i20","volume":"12","author":"PJ Beumont","year":"2003","unstructured":"Beumont PJ, Touyz SW. What kind of illness is anorexia nervosa? Eur Child Adolesc Psychiatry. 2003;12(1):i20\u20134.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"833_CR2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, A. and A.P. Association, Diagnostic and statistical manual of mental disorders: DSM-5. 2013, Washington, DC: American psychiatric association.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"833_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.physbeh.2015.06.007","volume":"152","author":"J Treasure","year":"2015","unstructured":"Treasure J, et al. New treatment approaches for severe and enduring eating disorders. Physiol Behav. 2015;152:456\u201365.","journal-title":"Physiol Behav"},{"key":"833_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cpr.2015.12.004","volume":"43","author":"JL Pennesi","year":"2016","unstructured":"Pennesi JL, Wade TD. A systematic review of the existing models of disordered eating: do they inform the development of effective interventions? Clin Psychol Rev. 2016;43:175\u201392.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"833_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17512433.2018.1383895","volume":"11","author":"H Himmerich","year":"2018","unstructured":"Himmerich H, Treasure J. Psychopharmacological advances in eating disorders. Expert Rev Clin Pharmacol. 2018;11(1):95\u2013108.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"833_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1017\/S1461145711000381","volume":"15","author":"MF Flament","year":"2012","unstructured":"Flament MF, Bissada H, Spettigue W. Evidence-based pharmacotherapy of eating disorders. Int J Neuropsychopharmacol. 2012;15(2):189\u2013207.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"833_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/eat.22085","volume":"46","author":"HJ Watson","year":"2013","unstructured":"Watson HJ, Fursland A, Byrne S. Treatment engagement in eating disorders: who exits before treatment? Int J Eat Disord. 2013;46(6):553\u20139.","journal-title":"Int J Eat Disord"},{"key":"833_CR8","doi-asserted-by":"crossref","unstructured":"Murray SB, Strober M, Tadayonnejad R, Bari AA, Feusner JD. Neurosurgery and neuromodulation for anorexia nervosa in the 21st century: a systematic review of treatment outcomes. Eat Disord. 2022;30(1):26\u201353.","DOI":"10.1080\/10640266.2020.1790270"},{"key":"833_CR9","unstructured":"InsideOut Institute for Eating Disorders. Australian Eating Disorders Research and Translation Strategy 2021\u20132031. Sydney; 2021. ."},{"key":"833_CR10","unstructured":"Virginia Commonwealth University. Research Guides: Rapid Review Protocol [Internet]. Rapid Review Protocol. [cited 2021 Jun 19]. Available from: https:\/\/guides.library.vcu.edu\/c.php?g=240398&p=1598530."},{"issue":"10227","key":"833_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","volume":"395","author":"SK Brooks","year":"2020","unstructured":"Brooks SK, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912\u201320.","journal-title":"Lancet"},{"key":"833_CR12","unstructured":"World Health Organisation. WHO | Rapid reviews to strengthen health policy and systems: a practical guide [Internet]. WHO. World Health Organization; [cited 2021 Jun 19]. Available from: http:\/\/www.who.int\/alliance-hpsr\/resources\/publications\/rapid-review-guide\/en\/."},{"key":"833_CR13","unstructured":"Canadian Agency for Drugs and Technologies in Health. About the Rapid Response Service | CADTH [Internet]. [cited 2021 Jun 19]. Available from: https:\/\/www.cadth.ca\/about-cadth\/what-we-do\/products-services\/rapid-response-service."},{"key":"833_CR14","doi-asserted-by":"crossref","unstructured":"Hamel C, Michaud A, Thuku M, Skidmore B, Stevens A, Nussbaumer-Streit B, et al. Defining rapid reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews. J Clin Epidemiol. 2020.","DOI":"10.1016\/j.jclinepi.2020.09.041"},{"issue":"7","key":"833_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med"},{"issue":"1","key":"833_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40337-022-00556-3","volume":"10","author":"P Aouad","year":"2022","unstructured":"Aouad P, et al. Informing the development of Australia\u2019s National Eating Disorders Research and Translation Strategy: a rapid review methodology. J Eat Disord. 2022;10(1):31.","journal-title":"J Eat Disord"},{"key":"833_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107667","volume":"217","author":"H Hubertus","year":"2021","unstructured":"Hubertus H, et al. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacol Ther. 2021;217: 107667.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"833_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40519-016-0253-0","volume":"21","author":"DM Garner","year":"2016","unstructured":"Garner DM, et al. Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations. Eat Weight Disord Stud Anorexia Bulimia Obes. 2016;21(3):395\u2013402.","journal-title":"Eat Weight Disord Stud Anorexia Bulimia Obes"},{"issue":"1","key":"833_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jadohealth.2015.03.021","volume":"57","author":"MC Monge","year":"2015","unstructured":"Monge MC, et al. Use of psychopharmacologic medications in adolescents with restrictive eating disorders: analysis of data from the National Eating Disorder Quality Improvement Collaborative. J Adolesc Health. 2015;57(1):66\u201372.","journal-title":"J Adolesc Health"},{"issue":"5","key":"833_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/erv.2240","volume":"21","author":"M Balestrieri","year":"2013","unstructured":"Balestrieri M, et al. Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy\/tolerability between adolescent and mixed-age population. Eur Eat Disord Rev. 2013;21(5):361\u201373.","journal-title":"Eur Eat Disord Rev"},{"issue":"4","key":"833_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.chc.2019.05.005","volume":"28","author":"J Couturier","year":"2019","unstructured":"Couturier J, et al. Psychotropic medication for children and adolescents with eating disorders. Child Adolesc Psychiatr Clin N Am. 2019;28(4):583\u201392.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"6","key":"833_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/erv.2788","volume":"28","author":"S Gorrell","year":"2020","unstructured":"Gorrell S, et al. Psychotropic medication use in treatment-seeking youth with eating disorders. Eur Eat Disord Rev. 2020;28(6):739\u201349.","journal-title":"Eur Eat Disord Rev"},{"issue":"3","key":"833_CR23","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1007\/BF03325129","volume":"16","author":"J Yu","year":"2011","unstructured":"Yu J, et al. A 1-year follow-up of a multi-center treatment trial of adults with anorexia nervosa. Eat Weight Disord Stud Anorexia Bulimia Obes. 2011;16(3):e177\u201381.","journal-title":"Eat Weight Disord Stud Anorexia Bulimia Obes"},{"issue":"5","key":"833_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/eat.22104","volume":"46","author":"JE Mitchell","year":"2013","unstructured":"Mitchell JE, Roerig J, Steffen K. Biological therapies for eating disorders. Int J Eat Disord. 2013;46(5):470\u20137.","journal-title":"Int J Eat Disord"},{"issue":"2","key":"833_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S1461145711000460","volume":"15","author":"PJ Hay","year":"2012","unstructured":"Hay PJ, Claudino AM. Clinical psychopharmacology of eating disorders: a research update. Int J Neuropsychopharmacol. 2012;15(2):209\u201322.","journal-title":"Int J Neuropsychopharmacol"},{"key":"833_CR26","doi-asserted-by":"crossref","unstructured":"M\u00e1rquez MC, S\u00e1nchez JM, Salazar AM, Mart\u00ednez CV, Valderrama F, Rojas-Gualdr\u00f3n DF. Efficacy and Safety of Antipsychotics and Antidepressants in the Treatment of Anorexia Nervosa: a Systematic Review. Rev Colomb Psiquiatr (Engl Ed). 2021.","DOI":"10.1016\/j.rcpeng.2022.08.007"},{"issue":"1","key":"833_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/j.1440-1665.2004.02154.x","volume":"13","author":"N Mondraty","year":"2005","unstructured":"Mondraty N, et al. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry. 2005;13(1):72\u20135.","journal-title":"Australas Psychiatry"},{"issue":"2","key":"833_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1017\/S1092852914000790","volume":"21","author":"M Miniati","year":"2016","unstructured":"Miniati M, et al. Psychopharmacological options for adult patients with anorexia nervosa. CNS Spectr. 2016;21(2):134\u201342.","journal-title":"CNS Spectr"},{"issue":"7","key":"833_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0006-3223(00)01013-1","volume":"49","author":"WH Kaye","year":"2001","unstructured":"Kaye WH, et al. Double-blind placebo-controlled administration of fluoxetine in restricting-and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001;49(7):644\u201352.","journal-title":"Biol Psychiatry"},{"issue":"22","key":"833_CR30","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1001\/jama.295.22.2605","volume":"295","author":"BT Walsh","year":"2006","unstructured":"Walsh BT, et al. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA. 2006;295(22):2605\u201312.","journal-title":"JAMA"},{"issue":"5","key":"833_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0924-977X(02)00058-5","volume":"12","author":"S Fassino","year":"2002","unstructured":"Fassino S, et al. Efficacy of citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharmacol. 2002;12(5):453\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"833_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jpsychires.2004.08.001","volume":"39","author":"K Holtkamp","year":"2005","unstructured":"Holtkamp K, et al. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res. 2005;39(3):303\u201310.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"833_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/erv.988","volume":"18","author":"RF McKnight","year":"2010","unstructured":"McKnight RF, Park RJ. Atypical antipsychotics and anorexia nervosa: a review. Eur Eat Disord Rev Prof J Eat Disord Assoc. 2010;18(1):10\u201321.","journal-title":"Eur Eat Disord Rev Prof J Eat Disord Assoc"},{"issue":"4","key":"833_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/eat.22059","volume":"46","author":"J Lebow","year":"2013","unstructured":"Lebow J, et al. The effect of atypical antipsychotic medications in individuals with anorexia nervosa: a systematic review and meta-analysis. Int J Eat Disord. 2013;46(4):332\u20139.","journal-title":"Int J Eat Disord"},{"issue":"10","key":"833_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","volume":"165","author":"MD Hany Bissada","year":"2008","unstructured":"Hany Bissada MD, et al. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2008;165(10):1281\u20138.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"833_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/eat.22704","volume":"50","author":"GK Frank","year":"2017","unstructured":"Frank GK, et al. The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa. Int J Eat Disord. 2017;50(4):447\u201350.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"833_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/erv.2169","volume":"20","author":"PS Powers","year":"2012","unstructured":"Powers PS, Klabunde M, Kaye W. Double-blind placebo-controlled trial of quetiapine in anorexia nervosa. Eur Eat Disord Rev. 2012;20(4):331\u20134.","journal-title":"Eur Eat Disord Rev"},{"issue":"10","key":"833_CR38","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1017\/S0033291711000390","volume":"41","author":"E Attia","year":"2011","unstructured":"Attia E, et al. Olanzapine versus placebo for out-patients with anorexia nervosa. Psychol Med. 2011;41(10):2177\u201382.","journal-title":"Psychol Med"},{"issue":"6","key":"833_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","volume":"176","author":"E Attia","year":"2019","unstructured":"Attia E, et al. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry. 2019;176(6):449\u201356.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"833_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/cap.2010.0131","volume":"21","author":"ML Norris","year":"2011","unstructured":"Norris ML, et al. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa. J Child Adolesc Psychopharmacol. 2011;21(3):213\u201320.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"833_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125569","volume":"10","author":"E Marzola","year":"2015","unstructured":"Marzola E, et al. Atypical antipsychotics as augmentation therapy in anorexia nervosa. PLoS ONE. 2015;10(4): e0125569.","journal-title":"PLoS ONE"},{"issue":"15","key":"833_CR42","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jpsychires.2010.03.011","volume":"44","author":"A Court","year":"2010","unstructured":"Court A, et al. Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: a pilot study. J Psychiatr Res. 2010;44(15):1027\u201334.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"833_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/erv.2495","volume":"25","author":"BP Nazar","year":"2017","unstructured":"Nazar BP, et al. Early response to treatment in eating disorders: a systematic review and a diagnostic test accuracy meta-analysis. Eur Eat Disord Rev. 2017;25(2):67\u201379.","journal-title":"Eur Eat Disord Rev"},{"issue":"9","key":"833_CR44","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jaac.2011.06.009","volume":"50","author":"J Hagman","year":"2011","unstructured":"Hagman J, et al. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. J Am Acad Child Adolesc Psychiatry. 2011;50(9):915\u201324.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"833_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/eat.22173","volume":"47","author":"A Andries","year":"2014","unstructured":"Andries A, et al. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. Int J Eat Disord. 2014;47(1):18\u201323.","journal-title":"Int J Eat Disord"},{"issue":"2","key":"833_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/eat.22811","volume":"51","author":"JA Lydecker","year":"2018","unstructured":"Lydecker JA, Shea M, Grilo CM. Driven exercise in the absence of binge eating: implications for purging disorder. Int J Eat Disord. 2018;51(2):139\u201345.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"833_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40519-014-0132-5","volume":"20","author":"A Andries","year":"2015","unstructured":"Andries A, Gram B, St\u00f8ving RK. Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial. Eat Weight Disord Stud Anorexia Bulimia Obes. 2015;20(1):13\u201321.","journal-title":"Eat Weight Disord Stud Anorexia Bulimia Obes"},{"issue":"9","key":"833_CR48","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2017.09.7095","volume":"17","author":"T Contreras","year":"2017","unstructured":"Contreras T, Bravo-Soto GA, Rada G. Do cannabinoids constitute a therapeutic alternative for anorexia nervosa? Medwave. 2017;17(9): e7095.","journal-title":"Medwave"},{"issue":"2","key":"833_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40519-020-00891-x","volume":"26","author":"EV Rosager","year":"2021","unstructured":"Rosager EV, M\u00f8ller C, Sj\u00f6gren M. Treatment studies with cannabinoids in anorexia nervosa: a systematic review. Eat Weight Disord. 2021;26(2):407\u201315.","journal-title":"Eat Weight Disord"},{"key":"833_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.psyneuen.2014.02.019","volume":"44","author":"Y-R Kim","year":"2014","unstructured":"Kim Y-R, et al. Intranasal oxytocin attenuates attentional bias for eating and fat shape stimuli in patients with anorexia nervosa. Psychoneuroendocrinology. 2014;44:133\u201342.","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"833_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/erv.2252","volume":"21","author":"S Maguire","year":"2013","unstructured":"Maguire S, et al. Oxytocin and anorexia nervosa: a review of the emerging literature. Eur Eat Disord Rev. 2013;21(6):475\u20138.","journal-title":"Eur Eat Disord Rev"},{"issue":"9","key":"833_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137514","volume":"10","author":"Y-R Kim","year":"2015","unstructured":"Kim Y-R, et al. The impact of oxytocin on food intake and emotion recognition in patients with eating disorders: a double blind single dose within-subject cross-over design. PLoS ONE. 2015;10(9): e0137514.","journal-title":"PLoS ONE"},{"key":"833_CR53","doi-asserted-by":"crossref","unstructured":"Leppanen J, Cardi V, Ng KW, Paloyelis Y, Stein D, Tchanturia K, et al. Effects of Intranasal Oxytocin on the Interpretation and Expression of Emotions in Anorexia Nervosa. J Neuroendocrinol. 2017;29(3).","DOI":"10.1111\/jne.12458"},{"key":"833_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psyneuen.2017.10.014","volume":"87","author":"J Russell","year":"2018","unstructured":"Russell J, et al. Intranasal oxytocin in the treatment of anorexia nervosa: randomized controlled trial during re-feeding. Psychoneuroendocrinology. 2018;87:83\u201392.","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"833_CR55","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.4088\/JCP.13m08365","volume":"74","author":"M Misra","year":"2013","unstructured":"Misra M, et al. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry. 2013;74(8):8644.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"833_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-018-1683-1","volume":"18","author":"G Paslakis","year":"2018","unstructured":"Paslakis G, et al. Prospective, randomized, double-blind, placebo-controlled phase IIa clinical trial on the effects of an estrogen-progestin combination as add-on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa. BMC Psychiatry. 2018;18(1):1\u201311.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"833_CR57","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1017\/S1461145710000982","volume":"14","author":"C Keating","year":"2011","unstructured":"Keating C, Tilbrook A, Kulkarni J. Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? Int J Neuropsychopharmacol. 2011;14(4):553\u201366.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"833_CR58","doi-asserted-by":"publisher","first-page":"7823","DOI":"10.4088\/JCP.17m11585","volume":"79","author":"PK Fazeli","year":"2018","unstructured":"Fazeli PK, et al. Treatment with a ghrelin agonist in outpatient women with anorexia nervosa: a randomized clinical trial. J Clin Psychiatry. 2018;79(1):7823.","journal-title":"J Clin Psychiatry"},{"key":"833_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104485","volume":"112","author":"V Karageorgiou","year":"2020","unstructured":"Karageorgiou V, et al. Adipokines in anorexia nervosa: a systematic review and meta-analysis. Psychoneuroendocrinology. 2020;112: 104485.","journal-title":"Psychoneuroendocrinology"},{"key":"833_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lfs.2017.04.015","volume":"178","author":"DJ Haleem","year":"2017","unstructured":"Haleem DJ. Improving therapeutics in anorexia nervosa with tryptophan. Life Sci. 2017;178:87\u201393.","journal-title":"Life Sci"},{"key":"833_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yclnex.2019.01.006","volume":"28","author":"N Achamrah","year":"2019","unstructured":"Achamrah N, D\u00e9chelotte P, Co\u00ebffier M. New therapeutic approaches to target gut-brain axis dysfunction during anorexia nervosa. Clin Nutr Exp. 2019;28:33\u201341.","journal-title":"Clin Nutr Exp"},{"key":"833_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.prostaglandins.2017.08.010","volume":"133","author":"PB Shih","year":"2017","unstructured":"Shih PB, et al. Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa. Prostaglandins Other Lipid Mediat. 2017;133:11\u20139.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"12","key":"833_CR63","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/eat.22964","volume":"51","author":"BE Manos","year":"2018","unstructured":"Manos BE, et al. A pilot randomized controlled trial of omega-3 fatty acid supplementation for the treatment of anxiety in adolescents with anorexia nervosa. Int J Eat Disord. 2018;51(12):1367\u201372.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"833_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/eat.10235","volume":"35","author":"NC Barbarich","year":"2004","unstructured":"Barbarich NC, et al. Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa. Int J Eat Disord. 2004;35(1):10\u20135.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"833_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14740338.2018.1395854","volume":"17","author":"NT Bello","year":"2018","unstructured":"Bello NT, Yeomans BL. Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder. Expert Opin Drug Saf. 2018;17(1):17\u201323.","journal-title":"Expert Opin Drug Saf"},{"key":"833_CR66","unstructured":"Hay, P.J. and A.M. Claudino, Bulimia nervosa. BMJ clinical evidence, 2010."},{"issue":"6","key":"833_CR67","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1017\/S0033291709991218","volume":"40","author":"R Sysko","year":"2010","unstructured":"Sysko R, et al. Early response to antidepressant treatment in bulimia nervosa. Psychol Med. 2010;40(6):999\u20131005.","journal-title":"Psychol Med"},{"issue":"11","key":"833_CR68","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","volume":"64","author":"SP Hoopes","year":"2003","unstructured":"Hoopes SP, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry. 2003;64(11):1335\u201341.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"833_CR69","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4088\/JCP.v64n1208","volume":"64","author":"DW Hedges","year":"2003","unstructured":"Hedges DW, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry. 2003;64(12):1449\u201354.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"833_CR70","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/eat.23480","volume":"54","author":"AR Keshen","year":"2021","unstructured":"Keshen AR, et al. A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa. Int J Eat Disord. 2021;54(5):872\u20138.","journal-title":"Int J Eat Disord"},{"issue":"2","key":"833_CR71","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.physbeh.2012.02.009","volume":"106","author":"MJ Devlin","year":"2012","unstructured":"Devlin MJ, et al. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent. Physiol Behav. 2012;106(2):238\u201342.","journal-title":"Physiol Behav"},{"issue":"1","key":"833_CR72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1037\/ccp0000358","volume":"87","author":"A Hilbert","year":"2019","unstructured":"Hilbert A, et al. Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder. J Consult Clin Psychol. 2019;87(1):91.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"833_CR73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14656566.2019.1571041","volume":"20","author":"G Amodeo","year":"2019","unstructured":"Amodeo G, et al. Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice. Expert Opin Pharmacother. 2019;20(6):679\u201390.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"833_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40519-013-0003-5","volume":"18","author":"CE Ramacciotti","year":"2013","unstructured":"Ramacciotti CE, et al. Therapeutic options for binge eating disorder. Eat Weight Disord. 2013;18(1):3\u20139.","journal-title":"Eat Weight Disord"},{"key":"833_CR75","unstructured":"Administration, T.G. Australian public assessment report for lisdexamfetamine dimesilate. 2018: Canberra."},{"issue":"5","key":"833_CR76","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/hup.2547","volume":"31","author":"AI Guerdjikova","year":"2016","unstructured":"Guerdjikova AI, et al. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial. Hum Psychopharmacol Clin Exp. 2016;31(5):382\u201391.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"833_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pscychresns.2019.03.003","volume":"286","author":"DE Fleck","year":"2019","unstructured":"Fleck DE, et al. Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder. Psychiatry Res Neuroimaging. 2019;286:53\u20139.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"6","key":"833_CR78","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M15-2455","volume":"165","author":"KA Brownley","year":"2016","unstructured":"Brownley KA, et al. Binge-eating disorder in adults: a systematic review and meta-analysis. Ann Intern Med. 2016;165(6):409\u201320.","journal-title":"Ann Intern Med"},{"issue":"1","key":"833_CR79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/14728214.2014.879291","volume":"19","author":"DL Reas","year":"2014","unstructured":"Reas DL, Grilo CM. Current and emerging drug treatments for binge eating disorder. Expert Opin Emerg Drugs. 2014;19(1):99\u2013142.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"3","key":"833_CR80","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","volume":"72","author":"SL McElroy","year":"2015","unstructured":"McElroy SL, et al. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiat. 2015;72(3):235\u201346.","journal-title":"JAMA Psychiat"},{"issue":"5","key":"833_CR81","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/npp.2015.275","volume":"41","author":"SL McElroy","year":"2016","unstructured":"McElroy SL, et al. Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2016;41(5):1251\u201360.","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"833_CR82","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/eat.22722","volume":"50","author":"SL McElroy","year":"2017","unstructured":"McElroy SL, et al. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder. Int J Eat Disord. 2017;50(8):884\u201392.","journal-title":"Int J Eat Disord"},{"issue":"3","key":"833_CR83","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/JCP.0000000000000702","volume":"37","author":"M Gasior","year":"2017","unstructured":"Gasior M, et al. A phase 3, multicenter, open-label, 12-month extension safety and tolerability trial of lisdexamfetamine dimesylate in adults with binge eating disorder. J Clin Psychopharmacol. 2017;37(3):315.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"833_CR84","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","volume":"74","author":"JI Hudson","year":"2017","unstructured":"Hudson JI, et al. Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiat. 2017;74(9):903\u201310.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"833_CR85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17425255.2018.1420163","volume":"14","author":"K Ward","year":"2018","unstructured":"Ward K, Citrome L. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder. Expert Opin Drug Metab Toxicol. 2018;14(2):229\u201338.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"833_CR86","doi-asserted-by":"publisher","first-page":"10400","DOI":"10.4088\/JCP.18m12378","volume":"80","author":"SG Kornstein","year":"2019","unstructured":"Kornstein SG, et al. Clinical characteristics and treatment response to lisdexamfetamine dimesylate versus placebo in adults with binge eating disorder: analysis by gender and age. J Clin Psychiatry. 2019;80(2):10400.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"833_CR87","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/ijcp.12639","volume":"69","author":"L Citrome","year":"2015","unstructured":"Citrome L. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication\u2014what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2015;69(4):410\u201321.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"833_CR88","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40261-016-0381-3","volume":"36","author":"T Agh","year":"2016","unstructured":"Agh T, et al. The cost effectiveness of lisdexamfetamine dimesylate for the treatment of binge eating disorder in the USA. Clin Drug Investig. 2016;36(4):305\u201312.","journal-title":"Clin Drug Investig"},{"key":"833_CR89","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.psychres.2019.01.066","volume":"273","author":"LC Quilty","year":"2019","unstructured":"Quilty LC, et al. A randomized comparison of long acting methylphenidate and cognitive behavioral therapy in the treatment of binge eating disorder. Psychiatry Res. 2019;273:467\u201374.","journal-title":"Psychiatry Res"},{"issue":"5","key":"833_CR90","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/eat.22493","volume":"49","author":"C Davis","year":"2016","unstructured":"Davis C, et al. Sex differences in subjective and objective responses to a stimulant medication (methylphenidate): comparisons between overweight\/obese adults with and without binge-eating disorder. Int J Eat Disord. 2016;49(5):473\u201381.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"833_CR91","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/YIC.0000000000000079","volume":"30","author":"SL McElroy","year":"2015","unstructured":"McElroy SL, et al. Armodafinil in binge eating disorder: a randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2015;30(4):209\u201315.","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"833_CR92","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1017\/S1092852920001406","volume":"26","author":"CM Grilo","year":"2021","unstructured":"Grilo CM, et al. Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial. CNS Spectr. 2021;26(5):481\u201390.","journal-title":"CNS Spectr"},{"issue":"5","key":"833_CR93","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.4088\/JCP.19m13068","volume":"81","author":"SL McElroy","year":"2020","unstructured":"McElroy SL, et al. Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, flexible-dose clinical trial. J Clin Psychiatry. 2020;81(5):5957.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"833_CR94","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/eat.23078","volume":"52","author":"JE Grant","year":"2019","unstructured":"Grant JE, et al. A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder. Int J Eat Disord. 2019;52(7):786\u201394.","journal-title":"Int J Eat Disord"},{"issue":"4","key":"833_CR95","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.4088\/JCP.12m08071","volume":"74","author":"MA White","year":"2013","unstructured":"White MA, Grilo CM. Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2013;74(4):2172.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"833_CR96","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-012-2778-x","volume":"224","author":"SR Chamberlain","year":"2012","unstructured":"Chamberlain SR, et al. Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals. Psychopharmacology. 2012;224(4):501\u20139.","journal-title":"Psychopharmacology"},{"issue":"3","key":"833_CR97","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/eat.22114","volume":"46","author":"SL McElroy","year":"2013","unstructured":"McElroy SL, et al. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder. Int J Eat Disord. 2013;46(3):239\u201345.","journal-title":"Int J Eat Disord"},{"issue":"10","key":"833_CR98","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s12325-017-0613-9","volume":"34","author":"AI Guerdjikova","year":"2017","unstructured":"Guerdjikova AI, et al. Concurrent improvement in both binge eating and depressive symptoms with naltrexone\/bupropion therapy in overweight or obese subjects with major depressive disorder in an open-label, uncontrolled study. Adv Ther. 2017;34(10):2307\u201315.","journal-title":"Adv Ther"},{"issue":"1","key":"833_CR99","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clinthera.2020.10.010","volume":"43","author":"CM Grilo","year":"2021","unstructured":"Grilo CM, et al. Naltrexone + bupropion combination for the treatment of binge-eating disorder with obesity: a randomized, controlled pilot study. Clin Therap. 2021;43(1):112-122.e1.","journal-title":"Clin Therap"},{"issue":"1","key":"833_CR100","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/eat.20876","volume":"44","author":"SL McElroy","year":"2011","unstructured":"McElroy SL, et al. Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. Int J Eat Disord. 2011;44(1):81\u201390.","journal-title":"Int J Eat Disord"},{"issue":"5","key":"833_CR101","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/S1092852920001613","volume":"26","author":"M Nourredine","year":"2021","unstructured":"Nourredine M, et al. Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis. CNS Spectr. 2021;26(5):459\u201367.","journal-title":"CNS Spectr"},{"issue":"2","key":"833_CR102","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/19390211.2016.1207124","volume":"14","author":"M Sala","year":"2017","unstructured":"Sala M, et al. A double-blind, randomized pilot trial of chromium picolinate for overweight individuals with binge-eating disorder: effects on glucose regulation. J Diet Suppl. 2017;14(2):191\u20139.","journal-title":"J Diet Suppl"},{"issue":"1","key":"833_CR103","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jpsychores.2013.03.092","volume":"75","author":"KA Brownley","year":"2013","unstructured":"Brownley KA, et al. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study. J Psychosom Res. 2013;75(1):36\u201342.","journal-title":"J Psychosom Res"},{"issue":"3","key":"833_CR104","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","volume":"9","author":"SA Robert","year":"2015","unstructured":"Robert SA, et al. Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide: a pilot study. Obes Res Clin Pract. 2015;9(3):301\u20134.","journal-title":"Obes Res Clin Pract"},{"issue":"01","key":"833_CR105","first-page":"20","volume":"121","author":"Z Pataky","year":"2013","unstructured":"Pataky Z, et al. Efficacy of rimonabant in obese patients with binge eating disorder. Exp Clin Endocrinol Diabetes. 2013;121(01):20\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"833_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cpr.2011.11.001","volume":"32","author":"JS Vander Wal","year":"2012","unstructured":"Vander Wal JS. Night eating syndrome: a critical review of the literature. Clin Psychol Rev. 2012;32(1):49\u201359.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"833_CR107","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/JCP.0b013e318254239b","volume":"32","author":"JS Vander Wal","year":"2012","unstructured":"Vander Wal JS, et al. Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial. J Clin Psychopharmacol. 2012;32(3):341\u20135.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"833_CR108","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.eatbeh.2013.02.001","volume":"14","author":"KC Allison","year":"2013","unstructured":"Allison KC, et al. An open-label efficacy trial of escitalopram for night eating syndrome. Eat Behav. 2013;14(2):199\u2013203.","journal-title":"Eat Behav"},{"issue":"4","key":"833_CR109","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.psc.2011.08.002","volume":"34","author":"KC Allison","year":"2011","unstructured":"Allison KC, Tarves E. Treatment of night eating syndrome. Psychiatr Clin N Am. 2011;34(4):785.","journal-title":"Psychiatr Clin N Am"},{"issue":"7","key":"833_CR110","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.5664\/jcsm.9236","volume":"17","author":"K Matsui","year":"2021","unstructured":"Matsui K, et al. The efficacy of add-on ramelteon and subsequent dose reduction in benzodiazepine derivatives\/Z-drugs for the treatment of sleep-related eating disorder and night eating syndrome: a retrospective analysis of consecutive patients. J Clin Sleep Med. 2021;17(7):1475\u201383.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"833_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinthera.2020.10.006","volume":"43","author":"DL Reas","year":"2021","unstructured":"Reas DL, Grilo CM. Psychotherapy and medications for eating disorders: better together? Clin Ther. 2021;43(1):17\u201339.","journal-title":"Clin Ther"},{"issue":"5","key":"833_CR112","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.medcli.2013.05.042","volume":"143","author":"A Larranaga","year":"2014","unstructured":"Larranaga A, et al. Comparative study of cognitive-behavioral psychotherapy and nutritional support in patients with different types of eating disorders. Med Clin. 2014;143(5):196\u2013200.","journal-title":"Med Clin"},{"issue":"6","key":"833_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11920-016-0696-z","volume":"18","author":"CM Grilo","year":"2016","unstructured":"Grilo CM, Reas DL, Mitchell JE. Combining pharmacological and psychological treatments for binge eating disorder: current status, limitations, and future directions. Curr Psychiatry Rep. 2016;18(6):55.","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"833_CR114","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1037\/a0030061","volume":"80","author":"CM Grilo","year":"2012","unstructured":"Grilo CM, et al. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder. J Consult Clin Psychol. 2012;80(6):1108.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"833_CR115","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/eat.20849","volume":"44","author":"KK Blomquist","year":"2011","unstructured":"Blomquist KK, Grilo CM. Predictive significance of changes in dietary restraint in obese patients with binge eating disorder during treatment. Int J Eat Disord. 2011;44(6):515\u201323.","journal-title":"Int J Eat Disord"},{"issue":"2","key":"833_CR116","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1037\/a0038635","volume":"83","author":"CM Grilo","year":"2015","unstructured":"Grilo CM, et al. Predicting meaningful outcomes to medication and self-help treatments for binge-eating disorder in primary care: the significance of early rapid response. J Consult Clin Psychol. 2015;83(2):387.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"833_CR117","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","volume":"22","author":"F Brambilla","year":"2007","unstructured":"Brambilla F, et al. Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol. 2007;22(4):197\u2013204.","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"833_CR118","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2174\/1570159X16666180108111532","volume":"16","author":"B Dalton","year":"2018","unstructured":"Dalton B, et al. Neurostimulation in clinical and sub-clinical eating disorders: a systematic update of the literature. Curr Neuropharmacol. 2018;16(8):1174\u201392.","journal-title":"Curr Neuropharmacol"},{"key":"833_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.psychres.2018.08.013","volume":"269","author":"F Rachid","year":"2018","unstructured":"Rachid F. Repetitive transcranial magnetic stimulation in the treatment of eating disorders: a review of safety and efficacy. Psychiatry Res. 2018;269:145\u201356.","journal-title":"Psychiatry Res"},{"key":"833_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nicl.2015.03.016","volume":"8","author":"D Val-Laillet","year":"2015","unstructured":"Val-Laillet D, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. NeuroImage Clin. 2015;8:1\u201331.","journal-title":"NeuroImage Clin"},{"key":"833_CR121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brat.2014.07.007","volume":"62","author":"RJ Park","year":"2014","unstructured":"Park RJ, Godier LR, Cowdrey FA. Hungry for reward: how can neuroscience inform the development of treatment for Anorexia Nervosa? Behav Res Ther. 2014;62:47\u201359.","journal-title":"Behav Res Ther"},{"issue":"4","key":"833_CR122","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S2215-0366(17)30076-7","volume":"4","author":"N Lipsman","year":"2017","unstructured":"Lipsman N, et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. The Lancet Psychiatry. 2017;4(4):285\u201394.","journal-title":"The Lancet Psychiatry"},{"key":"833_CR123","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.appet.2017.03.006","volume":"124","author":"PA Hall","year":"2018","unstructured":"Hall PA, Vincent CM, Burhan AM. Non-invasive brain stimulation for food cravings, consumption, and disorders of eating: a review of methods, findings and controversies. Appetite. 2018;124:78\u201388.","journal-title":"Appetite"},{"issue":"3","key":"833_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148606","volume":"11","author":"J McClelland","year":"2016","unstructured":"McClelland J, et al. A randomised controlled trial of neuronavigated repetitive transcranial magnetic stimulation (rTMS) in anorexia nervosa. PLoS ONE. 2016;11(3): e0148606.","journal-title":"PLoS ONE"},{"issue":"7","key":"833_CR125","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021531","volume":"8","author":"D Bethan","year":"2018","unstructured":"Bethan D, et al. Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study. BMJ Open. 2018;8(7): e021531.","journal-title":"BMJ Open"},{"key":"833_CR126","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.nicl.2015.06.008","volume":"8","author":"K Dunlop","year":"2015","unstructured":"Dunlop K, et al. Increases in frontostriatal connectivity are associated with response to dorsomedial repetitive transcranial magnetic stimulation in refractory binge\/purge behaviors. NeuroImage Clin. 2015;8:611\u20138.","journal-title":"NeuroImage Clin"},{"issue":"6","key":"833_CR127","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/erv.2475","volume":"24","author":"A Gay","year":"2016","unstructured":"Gay A, et al. A lack of clinical effect of high-frequency r TMS to dorsolateral prefrontal cortex on bulimic symptoms: a randomised, double\u2010blind trial. Eur Eat Disord Rev. 2016;24(6):474\u201381.","journal-title":"Eur Eat Disord Rev"},{"issue":"10","key":"833_CR128","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/eat.22554","volume":"49","author":"EE Burgess","year":"2016","unstructured":"Burgess EE, et al. Effects of transcranial direct current stimulation (tDCS) on binge-eating disorder. Int J Eat Disord. 2016;49(10):930\u20136.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"833_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167606","volume":"12","author":"M Kekic","year":"2017","unstructured":"Kekic M, et al. Single-session transcranial direct current stimulation temporarily improves symptoms, mood, and self-regulatory control in bulimia nervosa: a randomised controlled trial. PLoS ONE. 2017;12(1): e0167606.","journal-title":"PLoS ONE"},{"key":"833_CR130","doi-asserted-by":"publisher","first-page":"169","DOI":"10.25259\/SNI_730_2020","volume":"12","author":"MI Potes","year":"2021","unstructured":"Potes MI, et al. The utility of deep brain stimulation surgery for treating eating disorders: a systematic review. Surg Neurol Int. 2021;12:169.","journal-title":"Surg Neurol Int"},{"issue":"9875","key":"833_CR131","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0140-6736(12)62188-6","volume":"381","author":"N Lipsman","year":"2013","unstructured":"Lipsman N, et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. The Lancet. 2013;381(9875):1361\u201370.","journal-title":"The Lancet"},{"issue":"3","key":"833_CR132","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.brs.2020.02.004","volume":"13","author":"W Liu","year":"2020","unstructured":"Liu W, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory anorexia nervosa: a long-term follow-up study. Brain Stimul. 2020;13(3):643\u20139.","journal-title":"Brain Stimul"},{"issue":"1","key":"833_CR133","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10640266.2016.1237810","volume":"25","author":"CR Pacanowski","year":"2017","unstructured":"Pacanowski CR, et al. Yoga in the treatment of eating disorders within a residential program: a randomized controlled trial. Eat Disord. 2017;25(1):37\u201351.","journal-title":"Eat Disord"},{"key":"833_CR134","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ctim.2019.07.021","volume":"46","author":"T Ostermann","year":"2019","unstructured":"Ostermann T, et al. Effects of yoga on eating disorders\u2014a systematic review. Complement Ther Med. 2019;46:73\u201380.","journal-title":"Complement Ther Med"},{"issue":"1","key":"833_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40337-016-0130-2","volume":"4","author":"A Hall","year":"2016","unstructured":"Hall A, et al. Use of yoga in outpatient eating disorder treatment: a pilot study. J Eat Disord. 2016;4(1):1\u20138.","journal-title":"J Eat Disord"},{"issue":"4","key":"833_CR136","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ctim.2009.05.002","volume":"17","author":"S McIver","year":"2009","unstructured":"McIver S, O\u2019Halloran P, McGartland M. Yoga as a treatment for binge eating disorder: a preliminary study. Complement Ther Med. 2009;17(4):196\u2013202.","journal-title":"Complement Ther Med"},{"issue":"2","key":"833_CR137","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/ijoy.IJOY_3_17","volume":"11","author":"KE Karlsen","year":"2018","unstructured":"Karlsen KE, et al. Effect of yoga in the treatment of eating disorders: a single-blinded randomized controlled trial with 6-months follow-up. Int J Yoga. 2018;11(2):166\u20139.","journal-title":"Int J Yoga"},{"issue":"4","key":"833_CR138","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jadohealth.2009.08.007","volume":"46","author":"TR Carei","year":"2010","unstructured":"Carei TR, et al. Randomized controlled clinical trial of yoga in the treatment of eating disorders. J Adolesc Health. 2010;46(4):346\u201351.","journal-title":"J Adolesc Health"},{"issue":"8","key":"833_CR139","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.eurpsy.2015.09.008","volume":"30","author":"S Sauchelli","year":"2015","unstructured":"Sauchelli S, et al. Physical activity in anorexia nervosa: How relevant is it to therapy response? Eur Psychiatry. 2015;30(8):924\u201331.","journal-title":"Eur Psychiatry"},{"issue":"3","key":"833_CR140","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/00048670802653323","volume":"43","author":"JM Mond","year":"2009","unstructured":"Mond JM, Calogero RM. Excessive exercise in eating disorder patients and in healthy women. Aust N Z J Psychiatry. 2009;43(3):227\u201334.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"833_CR141","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ebmental-2018-300064","volume":"22","author":"A Ibrahim","year":"2019","unstructured":"Ibrahim A, Cutinha D, Ayton A. What is the evidence for using bed rest as part of hospital treatment of severe anorexia nervosa? Evid Based Ment Health. 2019;22(2):77\u201382.","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"833_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physio.2012.05.006","volume":"99","author":"L Ng","year":"2013","unstructured":"Ng L, Ng D, Wong W. Is supervised exercise training safe in patients with anorexia nervosa? A meta-analysis. Physiotherapy. 2013;99(1):1\u201311.","journal-title":"Physiotherapy"},{"issue":"2","key":"833_CR143","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mhpa.2013.04.002","volume":"6","author":"FJ Moola","year":"2013","unstructured":"Moola FJ, Gairdner SE, Amara CE. Exercise in the care of patients with anorexia nervosa: a systematic review of the literature. Ment Health Phys Act. 2013;6(2):59\u201368.","journal-title":"Ment Health Phys Act"},{"issue":"3","key":"833_CR144","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40519-015-0182-3","volume":"20","author":"S Schlegel","year":"2015","unstructured":"Schlegel S, et al. The Freiburg sport therapy program for eating disordered outpatients: a pilot study. Eat Weight Disord Stud Anorexia Bulimia Obes. 2015;20(3):319\u201327.","journal-title":"Eat Weight Disord Stud Anorexia Bulimia Obes"},{"key":"833_CR145","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.appet.2015.01.024","volume":"89","author":"JS Vander Wal","year":"2015","unstructured":"Vander Wal JS, et al. Education, progressive muscle relaxation therapy, and exercise for the treatment of night eating syndrome. A pilot study. Appetite. 2015;89:136\u201344.","journal-title":"Appetite"},{"key":"833_CR146","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.eatbeh.2016.03.002","volume":"21","author":"S Fogarty","year":"2016","unstructured":"Fogarty S, Smith CA, Hay P. The role of complementary and alternative medicine in the treatment of eating disorders: a systematic review. Eat Behav. 2016;21:179\u201388.","journal-title":"Eat Behav"},{"issue":"5","key":"833_CR147","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11920-015-0573-1","volume":"17","author":"SL McElroy","year":"2015","unstructured":"McElroy SL, et al. Psychopharmacologic treatment of eating disorders: emerging findings. Curr Psychiatry Rep. 2015;17(5):35.","journal-title":"Curr Psychiatry Rep"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-023-00833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-023-00833-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-023-00833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T10:05:14Z","timestamp":1688637914000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeatdisord.biomedcentral.com\/articles\/10.1186\/s40337-023-00833-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":147,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1186\/s40337-023-00833-9","relation":{},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ST receives royalties from Hogrefe and Huber, McGraw Hill and Taylor and Francis for published books\/book chapters. He has received honoraria from the Takeda Group of Companies for consultative work, public speaking engagements and commissioned reports. He has chaired their Clinical Advisory Committee for Binge Eating Disorder. He is the Editor in Chief of the Journal of Eating Disorders. ST is a committee member of the National Eating Disorders Collaboration as well as the Technical Advisory Group for Eating Disorders. AL undertook work on this Rapid Review while employed by HMA. SM is a guest editor of the special issue \u201cImproving the future by understanding the present: evidence reviews for the field of eating disorders.\u201d","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}